A new clinical trial in the emergency department finds no difference in efficacy or adverse effects of three commonly used treatments for patients with refractory status epilepticus.
New stem cell research reveals dangerous cardiac effects of a gene mutation in patients with Dravet syndrome.
People with medication-resistant epilepsy haven’t had many options. Now, a minimally invasive procedure uses lasers to stop the seizures.
Data show that the majority of neonatal epilepsy is linked to identifiable genetic causes, which may help guide treatment and family genetic counseling.
Every year, 1 in 1,000 people with epilepsy dies suddenly. Scientists are using stem cells from children with rare seizure disorders to find answers and potentially guide treatment.
Not all children with epilepsy have access to specialized care and may risk serious and far-reaching side effects. U-M is leading a collaborative to change this situation.